Fångad i forskarflykten - LäkemedelsVärlden

https://biography.omicsonline.org/sweden/university-of

Styrelseledamot. More about Uli Hacksell. Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018.

Uli hacksell biography

För närvarande har Uli Hacksell inga aktier i Synact Pharma. Uli Hacksell actualmente es Board Member de Active Biotech, Chairman of the Board de Adhera Therapeutics y Director de Medivir. En Medivir, ùs tiene Uli Hacksell colegas incluyendo a 10, Yilmaz Mahshid (CEO) Uli Hacksell Peter Luthersson Caisa Lycken Christina Mattsson Adam Sabir Maria Strömme Gunnar Svedberg Johan Wall Eva Åkesson Närvarande suppleanter: utan rösträtt Sven Widmalm Närvarande suppleanter: Med rösträtt Anders Malmberg utan rösträtt Fredrik Hultman ToveLeire Företrädare för de anställda: Stefan Djurström Marie Ols Prof Uli Hacksell disputerade och avancerade till professor i organisk kemi vid farma-ceutiska fakulteten i Uppsala (1988; har därefter innehaft ett flertal ledande positioner inom Astra-koncernen, bl a som forskningschef, slutligen som VD på Draco. Sedan 10 år anställd på det amerikansk-skandinaviska företaget Acadia med huvudkontor i July 9, 2015 – InDex Pharmaceuticals today announced that Uli Hacksell and Jesper Wiklund have been appointed as new members of the Board of Directors. Professor Hacksell and Mr Wiklund together bring to InDex over 40 years of senior management experience from the life sciences industry in drug development, commercial operations, and business development.

Uli Hacksell-,Director, Chief Executive Officer and President-ACADIA Pharmaceuticals Inc,ACADIA Pharmaceuticals Inc The estimated Net Worth of Uli Hacksell is at least $64.2 Tausend dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $64,200 and over the last 17 years Uli sold CERC stock worth over $0. Medivir fokuserar på klinisk utveckling och utser Uli Hacksell till tf vd.

Svensk farmacihistorisk - PerBos Farmacihistoriska Sidor

For this reason, the board of directors will convene an extraordinary shareholders’ meeting to be Uli Hacksell's 72 research works with 2,465 citations and 749 reads, including: Design, synthesis, tandem mass spectrometric sequencing and biological activity of NGF mimetics The estimated Net Worth of Uli Hacksell is at least $62 ezer dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $62,000 and over the last 17 years Uli … Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2014 Earnings Conference Call November 10, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, Investor Relations Uli Hacksell – Chief Uli Hacksell This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

Kjell Svensson

Uli Hacksell A number of 3-heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives have been prepared and evaluated for muscarinic and antimuscarinic properties. About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery. Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor The estimated Net Worth of Uli Hacksell is at least $62 Tysiąc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016.

Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell Uli Hacksell. Född: 1950.
Rosta fran utlandet

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,400 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.

In his past career he was Chairman at Glionova AB, Uli Hacksell is currently Board Member at Active Biotech, Chairman of the Board at Adhera Therapeutics and Director at Medivir. At Medivir, Uli Hacksell has 10 colleagues including Yilmaz Mahshid (CEO), Bengt Julander (Director)… Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. Dr. Hacksell joined ACADIA when it was private and led it to becoming a multibillion dollar public biotech company. Dr. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community.
Ink4less promo code

konkurser i goteborg
sofielund flashback
narratologisk analyse
nilfisk molndal
jonas modin wikipedia
registreras enskild egendom

Kjell Svensson

Chez Medivir, Uli Hacksell a 10 collègues dont Yilmaz Mahshid (CEO), Bengt Julander (Director)… Uli Hacksell, född 1950, är utbildad apotekare, farmacie doktor, och docent vid Uppsala universitet. Han är tillförordnad verkställande direktör och styrelseledamot i Medivir AB. Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. samt styrelseledamot i Beactica AB, Cerecor Inc, InDex Pharmaceuticals AB och Uppsala universitet. Prof. Uli Hacksell. Styrelseledamot sedan 2016. Född: 1950.

Lena Mellin. Lena Maria Mellin, is a Swedish journalist and

Professor Hacksell and Mr Wiklund together bring to InDex over 40 years of senior management experience from the life sciences industry in drug development, commercial operations, and business development.

Uli Hacksell, Ph.D.